Involvement of peroxisome proliferatoreactivated receptor gamma in vitamin Demediated protection against acute kidney injury in rats

Journal of Surgical Research

Volumn 185, Issue 2, 2013, Pages 774-783

  Kapil, Akanksha ^a   Singh, Jaswinder Pal ^a   Kaur, Tajpreet ^b   Singh, Balbir ^a   Singh, Amrit Pal ^a  

^a GURU NANAK DEV UNIVERSITY   (India)

^b KHALSA COLLEGE   (India)

Author keywords

Acute kidney injury; Oxidative stress; PPAR g; Vitamin D

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CALCIUM ION; CATALASE; CREATININE; EOSIN; ETHER; GLUTATHIONE; HEMATOXYLIN; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA; URIC ACID; VITAMIN D; CALCIUM; POTASSIUM; VITAMIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CALCIUM CELL LEVEL; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CREATININE CLEARANCE; KIDNEY INJURY; KIDNEY ISCHEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; RAT; RENAL PROTECTION; REPERFUSION INJURY; SODIUM EXCRETION; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; URINE; WISTAR RAT; DRUG EFFECT; PPAR-Γ;

ACUTE KIDNEY INJURY; ANIMALS; CALCIUM; CREATININE; DISEASE MODELS, ANIMAL; L-LACTATE DEHYDROGENASE; MALE; OXIDATIVE STRESS; POTASSIUM; PPAR GAMMA; RATS; RATS, WISTAR; REPERFUSION INJURY; UREA; URIC ACID; VITAMIN D; VITAMINS;

ACUTE KIDNEY INJURY; OXIDATIVE STRESS; PPAR-Γ; VITAMIN D;

EID: 84891698131     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.07.017     Document Type: Article

References (34)

1. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:31.
2. Jefayri MK, Grace PA, Mathie RT. Attenuation of reperfusion injury by renal ischemia preconditioning: role of NO. BJU Int 2000;85:1007.
3. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996;334:1448.
4. Braun AB, Gibbons FK, Litonjua AA, et al. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med 2012;40:63.
5. Kim YO, Li C, Sun BK, et al. Preconditioning with 1, 25-dihydroxyvitamin D3 protects against subsequent ischemia-reperfusion injury in the rat kidney. Nephron Exp Nephrol 2005;100:85.
6. 3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol 2004;286:526.
7. Li YC, Kong J, Wei M, et al. 1, 25-dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229.
8. Hamden K, Carreau S, Jamoussi K, et al. 1 Alpha, 25 dihydroxyvitamin D3: therapeutic and preventive effects against oxidative stress, hepatic, pancreatic and renal injury in alloxan-induced diabetes in rats. J Nutr Sci Vitaminol (Tokyo) 2009;55:215.
9. Sivarajah A, Chatterjee PK, Patel NS, et al. Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury. Am J Nephrol 2003;4:267.
10. Dai X, Sayama K, Shirakata Y, et al. PPAR gamma is an important transcription factor in 1 alpha, 25-dihydroxyvitamin D3-induced involucrin expression. J Dermatol Sci 2008;50:53.
11. Woeckel VJ, Bruedigam C, Koedam M, et al. 1a, 25-dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization. Gene 2013;512:438.
12. Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206.
13. Krawisz JE, Sharon P, Stenson W. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344.
14. Nichans WG, Samuelson B. Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968;6:126.
15. Singh R, Singh AP, Singh M, et al. Impact of obesity on hypertension-induced cardiac remodeling: role of oxidative stress and its modulation by gemfibrozil treatment in rats. Free Radic Biol Med 2011;50:363.
16. Aebi H, Wyss SR, Scherze B, et al. Heterogenecity of erythrocyte catalase II. Isolation and characterization of normal and variant erythrocyte catalase and their subunit. Eur J Biochem 1974;17:307.
17. Zimmerman BJ, Granger DN. Reperfusion injury. Surg Clin North Am 1992;72:65.
18. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003;14:2199.
19. Tibbles LA, Woodgett JR. The stress-activated protein kinase pathways. Cell Mol Life Sci 1999;55:1230.
20. Safirstein RL. Gene expression in nephrotoxic and ischemic acute renal failure. J Am Soc Nephrol 1994;4:1387.
21. Di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol 1999;277:195.
22. Matsuyama M, Nakatani T, Hase T, et al. The expression of cyclooxygenases and lipoxygenases in renal ischemia-reperfusion injury. Transplant Proc 2004;36:1939.
23. Chatterjee PK, Zacharowski K, Cuzzocrea S, et al. Inhibitors of poly (ADP-ribose) synthetase reduce ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J 2000;14:641.
24. Naka Y, Roy DK, Smerling AJ, et al. Inhaled nitric oxide fails to confer the pulmonary protection providedby distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. J Thorac Cardiovasc Surg 1995;110:1434.
25. Chatterjee PK. The cyclopentenone prostaglandin 15-deoxydelta (12, 14)-prostaglandin J2 ameliorates ischemic acute renal failure. Cardiovasc Res 2004;61:630.
26. Guan Y. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. J Am Soc Nephrol 2004;15:2801.
27. Panchapakesan U, Sumual S, Pollock CA, et al. PPAR gamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol 2005; 289:1153.
28. Delerive P, Martin-Nizard F, Chinetti G, et al. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 1999; 85:394.
29. Levi M, Molitoris BA, Burke TJ, et al. Effects of vitamin-induced chronic hypercalcemia on rat renal cortical plasma membranes and mitochondria. Am J Physiol 1987; 252:267.
30. Choi KH, Edelstein CL, Gengaro P, et al. Hypoxia induces changes in phospholipase A2 in rat proximal tubules evidence for multiple forms. Am J Physiol 1995; 269:846.
31. Conger JD, Robinette JB, Schrier RW. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest 1988; 82:532.
32. Edelstein CL, Yaqoob MM, Schrier RW. The role of the calcium-dependent enzymes nitric oxide synthase and calpain in hypoxia-induced proximal tubule injury. Ren Fail 1996;18:501.
33. Wang W, Li C, Kwon TH, et al. Reduced expression of renal Na transporters in rats with PTH-induced hypercalcaemia. Am J Physiol Renal Physiol 2004;286:F534.
34. Meng Q, Wong YT, Chen J, et al. Age-related changes in mitochondrial function and antioxidative enzyme activity in fischer 344 rats. Mech Ageing Dev 2007;128:286.